Testing a Cognitive-Behavioral OCD Prevention Program for Adults at Risk in a Randomized Clinical Trial

What this Trial Is About

Researchers are evaluating a prevention program for adults at risk of developing Obsessive-Compulsive Disorder OCD in a randomized clinical trial. The study aims to test whether this program can effectively reduce OCD symptoms and serve as a form of tertiary prevention. The trial is sponsored by Babes-Bolyai University and includes adults aged 18 to 65 years. Participants will be randomly assigned to one of two groups. The experimental group will take part in a two-week OCD prevention program consisting of six online group sessions using cognitive and behavioral strategies to lower OCD risk factors and related symptoms. The control group will receive treatment as usual and will not participate in the prevention program. During the study, participants will be assessed at baseline and after two weeks to measure changes in OCD symptoms, depression, and anxiety using standardized scales. Additional evaluations will assess changes in experiential avoidance, cognitive distortions, intolerance of uncertainty, and resilience. The study is double-blinded, and participants will be monitored for these outcomes throughout the intervention period.

An OCD Prevention Programme for at Risk Adults